Since overexpression of CIP2A can upregulate the drug resistance of tumor cells to chemotherapy [92], it is plausible that suppressing CIP2A signaling may make tumors that were resistant to some chemotherapies sensitive to this treatment again. The gene discussed is CIP2A; the disease is neoplasm.